Skip to content
Search

Latest Stories

PDA meet highlights ongoing impact of Covid-19 pandemic

The PDA said a recent Regional Committee meeting has discussed the impact of Covid-19 pandemic, staff shortages and an increase in reports of abuse and violence towards pharmacy teams, among other major issues.

The meeting highlighted the ongoing impact of the Covid-19 pandemic across all regions and sectors; particularly in the community sector, which has been the first face-to-face port of call for patients.


Many pharmacists across the UK have been crucial to the Covid-19 vaccination efforts, though in Scotland barriers prevented many pharmacists from being involved. Members have described this area of work as worthwhile and fulfilling, although it has been labour-intensive and the supply of lateral flow tests has been a tricky issue, with demand far outstripping supply at times.

Staffing issues have also been prevalent, with a shortage of staff in pharmacies made worse by the need for team members to self-isolate, sometimes with no replacement staff available which heightened the issue of pharmacy closures.

In hospitals, pharmacy teams are at the forefront of treating patients who are seriously ill. All of these factors have led to an increase of pressure on pharmacists at a time when the PDA has also seen an increase in reports of abuse and violence towards pharmacy teams. The PDA’s campaign on zero tolerance of abuse in pharmacies has been welcomed along with the accompanying risk assessment tools.

Northern Ireland

In Northern Ireland, the Omicron variant surge in the hospital pharmacy sector has left staffing at critical levels. The hospital discharge process had been impacted by recent action to decline new Medi-Dose patients by Community Pharmacy NI (CPNI), the body representing community pharmacy contractors throughout Northern Ireland. CPNI action had additionally impacted on GP Federations.

Scotland

In Scotland, issues of concern ranged from the cleanliness and standards in some community pharmacies to the influx of technicians into primary care roles. PDA members were concerned about burnt-out workforces and unrealistic expectations of what community pharmacists can deliver with bare minimum staffing levels that do not meet what the Scottish NHS contract demands. The PDA’s work monitoring and highlighting pharmacy closures was also discussed.

North and South East

The North and South East Regional Committees discussed the PDA Safer Pharmacies Charter and the results from the 2021 Safer Pharmacies Survey, which revealed an unacceptable decline in working conditions. Particular issues highlighted were around staffing levels, lack of rest breaks, and professional judgement.

In the North of England, members raised the need for pharmacists to have protected paid training time. This is due to continuing pressures being put on individuals to train for services in their own time for which providers and companies are paid.

In the South East region of England, the issue of training was discussed, with regards to accreditation around independent prescribing access and funding. Members talked about pay in the hospital sector being limited to trust-specific banding, encouraging more locums than permanent staff in this sector.

Wales and West

In Wales and the West of England, members discussed concerns around community pharmacy closures, increasing the workload to surrounding pharmacies, as well as the impact on pharmacist members of pharmacy technicians being made redundant. In the primary care sector, there was uncertainty around pharmacists’ job roles, especially if they are not a prescriber, and what training is available to this sector in Wales.

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less